ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.

The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Taking too long to enter the phase of sleep in which we dream may be an early sign of Alzheimer's disease. This is the ...

Key Takeaways Untreated sleep apnea contributes to car crashesPatients who got no treatment were 21% more likely to be in a ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Just as food, water, and air are essential for survival, sleep is also crucial for our overall health and well-being.

Medical conditions that deprive the testes of oxygen, such as sleep apnea, may be contributing to the decline in male fertility observed over the past 50 years, a new study suggests.

When most people think about sleep apnea, I’d assume they think of snoring. Snoring is just one type of sleep apnea that most ...

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...